Auszug
Das Auftreten eines malignen Tumorgeschehens in der Schwangerschaft gehört zu den eher seltenen klinischen Ereignissen. Schätzungsweise bei 0,07–0,1% aller Schwangerschaften wird eine maligne Tumorerkrankung neu diagnostiziert. Malignome des Ovars in der Schwangerschaft, hier insbesondere das epitheliale Karzinom, sind nach dem Zervix- und Mammakarzinom die dritthäufigsten gynäkologischen Malignome (Greenlee et al. 2001).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agarwal N, Parul, Kriplani A, Bhatla N, Gupta A. Management and outcome of pregnancies complicated with adnexal masses. Arch Gynecol Obstet 2003; 267: 148–152
Anderson ML, Mari G, Schwartz PE. Placental and fetal cancers. In: Barnea ER, Jauniaux E, Schwartz PE (eds) Cancer and pregnancy. Springer, London, 2001, pp 33–49
Arango HA, Kalter CS, Decesare SL, Fiorica JV, Iyman GH, Spellacy WN. Managrement of chemotherapy in a pregnancy complicated by a large neuroblastoma. Ostet Gynecol 1994; 84: 665–668
Bakri YN, Ezzat A, Akthar M, Dohami H, Zahrani A. Malignant germ cell tumors of the ovary. Pregnancy considerations. Eur J Obstet Gynecol Reprod Biol 2000; 90: 87–91
Bayhan G, Alban M, Yayla M, Gil T, Yaldiz M, Erden AC. Cisplatinum combination chemotherapy during pregnancy, for mucinous cystadenocarcinoma of the ovary. Case report. Eur J Gynaecol Oncol 1999; 20: 231–232
Benjamin I, Morgan MA, Rubin SC. Occult bilateral involvement in Stage I epithelial ovarian cancer. Gynecol Oncol 1999; 72: 288–291
Boran N, Cil AP, Tulunay G et al. Fertility and recurrence results of conservative surgery of borderline ovarian tumours. Gynecol Oncol 2005; 97: 845–857
Bostwick D, Tazelaar H, Ballon S et al. Ovarian epithelial tumors of borderline malignancy. A clinical and pathological study of 109 cases. Cancer 1986; 58: 2052–2065
Boulay R, Podczaski E. Ovarian cancer complicating pregnancy. Obstet Gynecol Clin N Am 1998; 25: 385–399
Brewer M, Gershenson DM, Herzog CE et al. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 1999; 17: 2670–2673
Camatte S, Rouzier R, Boccara-Dekeyser J et al. Prognostic et fertilité après traitemant conservateur d’une tumeur ovarienne à la limite de la malignité: revue d’une série continue des 68 cas. Gynecol Obstet Fertil 2002; 30: 583–591
Cardonick E, Iacobucci A. Use of chemotherapy durino human pregnancy. Lancet 2004; 5: 283–291
CD Ovarialkarzinom — State of the Art, Symposium der Komission Ovar der AGO, 10.–11. Juni 2005 in Stuttgart
Colombo N, Parma G, Lapresa MT, Maggi F, Piantanida P, Maggioni A. Role of conservative surgery of ovarian cancer: the European experience. Int J Gynecol Cancer 2005; 15(Suppl.3): 206–211
Dgani R, Shoham Z, Atar E, Zosmer A, Lancet M. Ovarian carcinoma during pregnancy: a study of 23 cases in Israel between the years 1960 and 1984. Gynecol Oncol 1989; 33: 326–331
DiSaia PJ, Creasman WT. Epithelial ovarian cancer. In: DiSaia PJ, Creasman WT (eds) Clinical gynaecologic oncology, 6. Ed. Mosby, St. Louis, 2002, pp 289–350
DiSaia PJ, Creasman WT. Cancer in pregnancy. In: DiSaia PJ, Creasman WT (eds) Clinical gynaecologic oncology, 6. Ed. Mosby, St. Louis, pp 446–472
Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16: 337–346
Donnez J, Munschke A, Berliere M, et al. Safety of conservative management and fertility outcome in women with borderline tumours of the ovary. Fertil Steril 2003; 79: 1216–1221
Dudkiewicz J, Kowalski T, Grzonka D, Czamecki M. Ovarian tumors in pregnancy. Ginekol Pol 2002; 73: 342–345
Ebert U, Löffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997; 74: 207–220
Elit L, Bocking A, Kenyon C, Natale R. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol 1999; 72: 123–127
Falkenberry SS. Cancer in pregnancy. Surg Oncol Clin N Am 1998; 7: 375–397
Fauvet R, Poncelet C, Boccara J et al. Fertility after conservative treatment for borderline ovarian tumours: a french multicentre study. Fertil Steril 2005; 97: 845–857
Fotiou SK. Ovarian malignancies in adolescence. Ann N Y Acad Sci 1997; 816: 338–346
Gershenson DM. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol 2000; 19: 69–75
Goffinet F. Ovarian cyst and pregnancy. J Gynecol Obstet Biol Reprod 2001; 30 Suppl 1: 100–108
Gotlieb WH, Flikker S, Davidson B et al. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 1998; 82: 141–146
Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2001; 51: 15–36
Henderson CE, Elia G, Garfinkel D et al. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynaecol Oncol 1993; 49: 92–94
Hermans RH, Fischer DC, Van der Putten HW et al. Adnexal masses in pregnancy. Onkologie 2003; 26: 167–172
Hogberg T, Gimelius B, Nguyen P. A systematic overview of chemotherapy effects in ovarian cancer. Acta Oncol 2001; 40: 340–360
Horbelt D, Delmore J, Meisel R, Cho S, Roberts D, Logan D. Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol 1994; 84: 662–664
Horner EN. Placental metastasis. Case report: maternal death from ovarian cancer. Obstet Gynecol 1960; 15: 566–572
Huang HP, Fang CN, Kan YY. Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: a case report. Eur J Gynaecol Oncol 2004; 25: 635–636
Jackisch C, Louwen F, Schwenkhagen A et al. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet 2003; 268: 69–77
Kai S, Kohmura H, Hiraiwa E et al. Reproductive and developmental toxicity studies of paclitaxel. (II)-Intravenous administration to rats during the fetal organogenesis. J Toxicol Sci 1994; 19; Suppl 1: 69–91
Kai S, Kohmura H, Ishikawa K et al. Teratogenic effects of carboplatin, an oncostatic drug, administered during the early organogenetic period in rats. J Toxicol Sci 1989; 14: 115–130
Karlen JR, Akbari A, Cook WA. Dysgerminoma associated with pregnancy. Obstet Gynecol 1979; 53: 330–335
Kindermann G, Maassen V, Kuhn W. Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 german gynecologic dinics. Geburtshilfe Frauenheilkd 1995; 55(12): 687–694
Lange S, Münstedt K. Onkologische Therapie in der Schwangerschaft. Gynäkologe 2004; 37: 492–499
Lecuru F, Desfeux P, Bissery A, Robin F, Blanc B, Querleu D. Stage I ovarian cancer: comparison of laparoscopy and laparotomy on staging and survival. Eur J Gynaecol Oncol 2004; 25(5): 571–576
Maneo A, Vignali M, Chiari S, Colombo A, Mangioni C, Bandoni F. Are borderline tumors of the ovary safely treated by laparoscopy? Gynecol Oncol 2004; 94(2): 387–392
Mendez LE, Mueller A, Salom E, Gonzales-Quintero VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynaecol 2003; 102: 1200–1202
Monk BJ, DiSaia PJ. What is the role of conservative primari surgical management of epithelial ovarian cancer: the United States experience and debate. Int J Gynecol Cancer 2005, 15(Suppl. 3), 199–205
Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer 2006; 42: 149–158
Morice P, Camatte S, Rey A et al. Prognostic factors of patients with advanced stage serous borderline tumour of the ovary. Ann Oncol 2003; 14: 592–598
Morice P, Leblanc E Rey A et al. Conservative treatment in epithelial ovarian cancer results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d’Oncologie Gynécologique). Hum Reprod 2005; 20: 1379–1385
Morris RT, Gershenson DM, Silva EG et al. Outcome and reproductive function after conservative surgery for borderline ovarian tumours. Obstet Gynecol 2000; 95: 541–547
Oeler MK, Wain GV, Brand A. Gynaecological malignancies in pregnancy: a review. Aust N Z J Obstet Gynaecol 2003; 43: 414–420
Otton G, Higgins S, Phillips KA, Quinn M. A case of early-stage epithelial ovarian cancer in pregnancy. Int J Gynecol Cancer 2001; 11: 413–417
Partridge EE, Phillips JL, Menck HR. The National Cancer Data Base report on ovarian cancer treatment in United States hospitals. Cancer 1996; 78: 2236–2246
Pentheroudakis G, Pavlidis N. Cancer and pregnancy: Poena magna, not anymore. Eur J Cancer 2006; 42: 126–140
Picone O, Lhommé C, Tournaire M et al. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol 2004; 94: 600–604
Pitynski K, Basta A, Szczudrawa A, Oplawski M. Ovarian tumors in pregnancy in the material a of the Department of Gynecology and Oncology Collegium Medicum of Jagiellonian University in Cracow. Ginekol Pol 2002; 73: 371–375
Raffles A, Williams J, Costelope K, Glarke P. Transplacental effects of maternal cancer chemotherapy: case report. Br J Ostet Gynaecol 1989; 96: 1099–1100
Rahman MS, Al-Sibai MH, Rahman J et al. Ovarian carcinoma associated with pregnancy. A review of 9 cases. Acta Obstet Gynecol Scand 2002; 81: 260–264
Raspagliesi F, Fontanelli R, Paladini D, Re EM di. Conservative surgery in high risk epithelial ovarian carcinoma. Am J Coll Surg 1997; 185: 457–460
Reidenbach F. Chemotherapy safe in pregnancy. Lancet 2002; 43: 53–59
Schilder JM, Thompson AM, DePriest PD et al. Outcome of reproductive age woman with stage IA or IC invasive epithelian ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002; 87: 1–7
Schwartz PE, Marchant D. Cancer in pregnancy. In: Reece EA, Hobbins JC (eds) Medicine of the fetus and mother, 2. Ed. Lippincott-Raven, Philadelphia, 1999, pp 1371–1396
Shay DC, Shankar KB, Datta S. Laparoscopic surgery during pregnancy. Anesthesiol Clin North Am 2001; 19(1): 57–67
Sood AK, Shahin MS, Sorosky JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001; 81: 599–600
Soriano D, Yefet Y, Seidman DS, Goldnebrg M, Mashich S, Oelsner G. laparoscopy versus laparotomy in the management of adnexal masses during pregnancy. Fertil Steril 1999; 71: 955–960
Tazelaar H, Bostwick D, Ballon S et al. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985; 66: 417–422
Tewari K, Capuccini F, Disaia PJ, Berman ML, Manetta A, Kohler, MF. Malignant germ cell tumors of the ovary. Obstet Gynecol 2000; 95: 128–133
Ueda M, Ueki M. Ovarian tumors associated with pregnancy. Int J Gynaecol Obstet 1996; 55: 59–65
Weed JC, Roh RA, Mendenhall HW. Recurrent endodermal sinus tumor during pregnancy. Obstet Gynecol 1997; 54: 653–656
Williams SD, Gershenson DM, Horowitz CJ. Ovarian germ-cell tumors. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and practice of gynaecologic oncology. Philadelphia, PA: Lippincott, 1996: 987–1001
Wimberger P, Hepp H, Kimmig R. Ovarialmalignome in der Schwangerschaft. Onkologe 2002; 8: 1323–1332
Young RH, Dudley AG, Scully RE. Granulosa cell, Sertoli-Leydig cell, and undassifiedsex-cord stromal tumors associated with pregnancy: a clinicopathological analysis of thirty-six cases. Gynecol Oncol 1984; 18: 181–205
Zanetta G, Bonazzi C, Cantù MG et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001a; 19: 1015–1020
Zanetta G, Chiari S, Rota S et al. Conservative surgery for stagel ovarian carcinomas in woman of childbearing age. Br J Obstet Gynaecol 1997; 104: 1030–1035
Zanetta G, Rota S, Chiari S et al. Behavior of borderline tumours with particolar interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. Clin Oncol 2001b; 19: 2658–2564
Zanotti KS, Belinson JL, Kennedy AW. Treatment of gynaecologic cancers in pregnancy. Semin Oncol 2000; 27: 686–698
Zemlickis D, Lishner M, Degendorfer P et al. Maternal and foetal outcome after invasive cervical cancer in pregnancy: a case-control study. Gynecol Oncol 1996; 63: 1956–1961
Zhao XY, Huang HF, Lian LJ, Lang JH. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer 2006; 16
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Jackisch, C., Thill, M. (2009). Maligne Ovarialtumoren in der Schwangerschaft. In: Management des Ovarialkarzinoms. Onkologie aktuell. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68857-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-540-68857-0_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41987-7
Online ISBN: 978-3-540-68857-0
eBook Packages: Medicine (German Language)